Skip to main content
. Author manuscript; available in PMC: 2020 Feb 10.
Published in final edited form as: Eur J Neurol. 2017 Oct 4;24(12):1464–1470. doi: 10.1111/ene.13440

Table 1.

Demographic variables by galectin-3 quartile (Q) in the cohort random sample*

Galectin-3 quartile
Q1 Q2 Q3 Q4 P value
Sample size
 Unweighted 220 237 222 268
 Weighted 6636 6502 6326 6401
Age (mean, years) 61.0 64.5 65.5 68.0 <0.001
Race (% white) 70 59 56 52 0.003
Sex (% male) 58 42 42 36 <0.001
Physical activity frequency (%)
 None 23 35 34 41 0.01
 1–3 times per week 41 33 41 32
 4+ times per week 36 32 25 28
BMI (mean, kg/m2) 27.8 29.2 30.6 29.6 <0.001
History of heart disease (% yes) 11 14 16 24 0.007
Hypertension (% yes) 46 59 63 75 <0.001
SBP (mean, mmHg) 125 127 128 129 0.002
Diabetes (% yes) 7 22 26 30 <0.001
LVH by ECG (% yes) 5 9 7 10 0.24
Atrial fibrillation 6 12 10 8 0.36
Income (%) <$20 000 11 15 15 22 <0.001
Education (%) <high school 6 11 11 18 0.001

BMI, body mass index; ECG, electrocardiography; LVH, left ventricular hypertrophy; SBP, systolic blood pressure, mmHg.

*

Analyses weighted to reflect distributions in the analytic cohort.